SKP2 and neoplasm: Xenograft tumors derived from Skp2-null HCT116 cells that were treated with irradiation exhibited reduced tumor growth (Fig. 6D), tumor mass (Fig. 6E), and tumor cell proliferation (Fig. 6F).